A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy

Cetuximab (CTX) is a monoclonal antibody targeting the epidermal growth factor receptor (EGFR), commonly used to treat patients with metastatic colorectal cancer (mCRC). Unfortunately, objective remissions occur only in a minority of patients and are of short duration, with a population of cells sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelfo, Valerio, Mazzeschi, Martina, Grilli, Giada, Lindzen, Moshit, Santi, Spartaco, D’Uva, Gabriele, Győrffy, Balázs, Ardizzoni, Andrea, Yarden, Yosef, Lauriola, Mattia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210663/
https://www.ncbi.nlm.nih.gov/pubmed/30261609
http://dx.doi.org/10.3390/cancers10100355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210663/
https://www.ncbi.nlm.nih.gov/pubmed/30261609
http://dx.doi.org/10.3390/cancers10100355

Ejemplares similares